Views: 0 Author: Site Editor Publish Time: 2025-11-21 Origin: Site
On November 12, Japanese endoscope manufacturer Ikeda officially released its 2025 product catalogue, highlighting the new generation of endoscope systems equipped with the latest CMOS image sensor. The core imaging platform has been fully upgraded to 4K Ultra High Definition (UHD) and Full HD (FHD) standards, marking the accelerated strategic transformation of this traditional endoscope manufacturer towards high-definition digitalization.
The highlight of this catalogue is the comprehensive adoption of Sony CMOS sensor technology, replacing the traditional CCD solution. CMOS technology not only achieves lower power consumption and smaller size, but also makes breakthroughs in frame rate and dynamic range, supporting 60fps smooth imaging at 4K resolution, providing unprecedented clarity for observing mucosal vascular microstructures and identifying the boundaries of early canceration. The full HD platform reduces noise in routine examinations through optimized algorithms, improving diagnostic efficiency.
Ikeda's move is intended to seize the high-definition upgrade benefits in the mid-range market. With a global 4K endoscope system annual growth rate exceeding 12%, its entry with the "CMOS + 4K" combination retains the durability and cost-effectiveness advantages of Japanese products while meeting the rigid demand for high-definition imaging in the European and American markets. Industry analysts point out that this product line may become a benchmark solution for grassroots hospitals to make the leap from "being able to see" to "being able to see clearly".
Ikeda's full-scale shift further confirms the trend of CMOS replacing CCD in the medical endoscope field. With faster reading speed and easier AI pre-processing capabilities, CMOS technology is becoming the basic hardware for intelligent endoscopes. It is expected that the price of 4K CMOS endoscopes will drop by 20%-30% in the next two years, driving the market penetration rate to rapidly increase from the current less than 15% to 30%.
Conclusion: Ikeda's 2025 catalogue is not only a product update but also a declaration of the technical route. In the era of deep integration of AI diagnosis and minimally invasive treatment, high-definition imaging is the "visual base" of future healthcare. This layout may reshape its global market position.
